Holen Sie sich die Stockscreener-App
10.46
1.32%
-0.14
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$10.60
Offen:
$10.8
24-Stunden-Volumen:
4.02M
Relative Volume:
0.91
Marktkapitalisierung:
$1.73B
Einnahmen:
$596.34M
Nettoeinkommen (Verlust:
$-87.84M
KGV:
-17.51
EPS:
-0.5975
Netto-Cashflow:
$-97.62M
1W Leistung:
-1.60%
1M Leistung:
+1.36%
6M Leistung:
+35.84%
1J Leistung:
+9.53%
1-Tages-Spanne:
$10.33
$10.86
1-Wochen-Bereich:
$10.26
$11.11
52-Wochen-Spanne:
$6.20
$11.97
Novavax Inc Stock (NVAX) Company Profile
Firmenname
Novavax Inc
Sektor
Branche
Telefon
240-268-2000
Adresse
21 FIRSTFIELD RD, GAITHERSBURG, MD
Compare NVAX vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
10.46 | 1.75B | 596.34M | -87.84M | -97.62M | -0.5975 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-24 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-08-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-08-20 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-06-17 | Eingeleitet | Citigroup | Sell |
| 2025-02-28 | Eingeleitet | BTIG Research | Buy |
| 2024-07-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-05-10 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-08-09 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | Bestätigt | B. Riley Securities | Buy |
| 2022-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2022-12-02 | Eingeleitet | Jefferies | Hold |
| 2022-09-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-05-20 | Eingeleitet | BofA Securities | Underperform |
| 2022-02-23 | Bestätigt | B. Riley Securities | Buy |
| 2022-02-22 | Fortgesetzt | Jefferies | Buy |
| 2022-01-21 | Eingeleitet | Cowen | Outperform |
| 2021-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
| 2020-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-08-05 | Herabstufung | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | Bestätigt | B. Riley FBR | Buy |
| 2020-06-29 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-05 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-05-28 | Bestätigt | B. Riley FBR | Buy |
| 2020-05-12 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-30 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-08-14 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-28 | Herabstufung | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-12-11 | Eingeleitet | Oppenheimer | Outperform |
| 2018-11-26 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2018-03-29 | Hochstufung | Seaport Global Securities | Neutral → Buy |
Alle ansehen
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Novavax (NVAX) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
NVAX: Daily Falling Wedge Setup Eyeing $11.13 Ahead of Q3 for NASDAQ:NVAX by TaxpayerTrades - TradingView
NVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds — Analyst Warns Of 20% Crash - Stocktwits
Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver? - Stocktwits
(NVAX) Volatility Zones as Tactical Triggers - Stock Traders Daily
Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts - stocktwits.com
Enterprise value to EBIT forward of Novavax, Inc. – BX:NVV1 - TradingView
Novavax stock falls 2.59 percent below its yearly high - AD HOC NEWS
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Novavax stock falls 2.54 percent below its yearly high - AD HOC NEWS
Novavax Inc (NVAX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Novavax Inc. Stock Rises 4.0%, Outperforms Peers - webull.com
Novavax, Inc. (NVAX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Novavax, Inc. (NVV1.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
Novavax stock gains as Q2 2026 revenue rises and vaccine focus deepens - AD HOC NEWS
Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue - Stocktwits
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Novavax (NVAX) Soars 7.0%: Is Further Upside Left in the Stock? - Yahoo Finance
Novavax Inc. (NVAX) Key Financial Ratios – Valuation, Profitability & More - Value Research
Do Novavax’s (NVAX) New Partnerships Offset Policy Risks From The Protecting Approved Care Act? - Yahoo Finance
Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know - Yahoo Finance
Novavax Inc. stock underperforms Tuesday when compared to competitors - marketwatch.com
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - finance.yahoo.com
Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know - Yahoo Finance
Novavax (NVAX) Laps the Stock Market: Here's Why - Yahoo Finance
ETFs Investing in Novavax, Inc. Stocks - TradingView
Novavax Inc Lobbyists, 2020 - opensecrets.org
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot - TradingView
Transcript : Novavax, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-10-2026 10:00 AM - marketscreener.com
Novavax at Citi summit: partnerships extend cash runway By Investing.com - Investing.com India
Novavax Highlights Matrix-M Licensing Push, Oncology Ambitions at Cantor Conference - Yahoo Finance
Novavax at cantor healthcare conference: pivot to licensing gains steam - investing.com
Novavax at cantor healthcare conference: pivot to licensing gains steam By Investing.com - Investing.com Canada
NVAX: Strategic shift to licensing and Matrix-M partnerships drives growth in vaccines and oncology - TradingView
NVAX: Major pharma partnerships, Matrix-M expansion, and global commercialization drive future growth - TradingView
GOOGL Stock Price TodayAlphabet Inc Class A News, Charts, Retail Sentiment - Stocktwits
Finanzdaten der Novavax Inc-Aktie (NVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):